ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Merck (Schweiz) AG - Mavenclad 10 mg, Tabletten
6683101
Mavenclad 10 mgTabletten
L04AA40Cladribine
19.03.2019  
Composition
cladribinum 10.00 mg, hydroxypropylbetadexum, sorbitolum 64.04 mg, magnesii stearas, pro compresso.
Packungsbestandteile
Tablets 
 
Active AgentDose
Cladribine10 mg
BAG: Active AgentDose
Cladribine10 mg
 
Inactive agentsDose
Hydroxypropylbetadexum 
Magnesii Stearas 
Pro Compresso 
Sorbitol64.04 mg
 
Package numberPackage SizeEFPCPCategorySLOut of trade (MedRef)
001 2348.192570.20ASLYes
00249392.769944.75ASLYes
003614089.1414763.25ASLYes
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home